OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NTRK fusions in thyroid cancer: Pathology and clinical aspects
Yanhui Ma, Qi Zhang, Kexin Zhang, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 184, pp. 103957-103957
Closed Access | Times Cited: 8
Yanhui Ma, Qi Zhang, Kexin Zhang, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 184, pp. 103957-103957
Closed Access | Times Cited: 8
Showing 8 citing articles:
CACA Technical guidelines for holistic integrative management of cancer —— genetic testing
Bing Wei, Jinliang Xing, Xiaoyan Zhou, et al.
Holistic Integrative Oncology (2025) Vol. 4, Iss. 1
Open Access
Bing Wei, Jinliang Xing, Xiaoyan Zhou, et al.
Holistic Integrative Oncology (2025) Vol. 4, Iss. 1
Open Access
Update papilläres Schilddrüsenkarzinom – Was ist für Chirurg*innen relevant?
Ann‐Kathrin Lederer, Thomas J. Musholt
Deleted Journal (2025)
Closed Access
Ann‐Kathrin Lederer, Thomas J. Musholt
Deleted Journal (2025)
Closed Access
Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis
Yoichiro Okubo, Soji Toda, Mei Kadoya, et al.
Virchows Archiv (2024) Vol. 485, Iss. 3, pp. 509-518
Open Access | Times Cited: 3
Yoichiro Okubo, Soji Toda, Mei Kadoya, et al.
Virchows Archiv (2024) Vol. 485, Iss. 3, pp. 509-518
Open Access | Times Cited: 3
Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
Xuejin Ou, Ge Gao, Inbar A. Habaz, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 3
Xuejin Ou, Ge Gao, Inbar A. Habaz, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 3
Metabolic Reprogramming in Thyroid Cancer
Sang Hyeon Ju, Minchul Song, Joung Youl Lim, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 3, pp. 425-444
Open Access | Times Cited: 2
Sang Hyeon Ju, Minchul Song, Joung Youl Lim, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 3, pp. 425-444
Open Access | Times Cited: 2
The value of preoperative molecular testing in the management of Bethesda V and Bethesda VI thyroid tumors
Άννα Πασπάλα, Georgia Bompetsi, Stavroula Α. Paschou, et al.
HORMONES (2024)
Closed Access | Times Cited: 1
Άννα Πασπάλα, Georgia Bompetsi, Stavroula Α. Paschou, et al.
HORMONES (2024)
Closed Access | Times Cited: 1
Optimal screening method for targetable gene rearrangements in papillary thyroid carcinoma with wild-type BRAF
Meihua Jin, Chae A Kim, Min Ji Jeon, et al.
Research Square (Research Square) (2024)
Open Access
Meihua Jin, Chae A Kim, Min Ji Jeon, et al.
Research Square (Research Square) (2024)
Open Access
NTRK-fusion detection in thyroid and salivary gland cancer offers a targeted therapy with NTRK-inhibitor
Hana Evangelin Prayogo, Willy Sandhika
GSC Biological and Pharmaceutical Sciences (2023) Vol. 25, Iss. 1, pp. 131-137
Open Access | Times Cited: 1
Hana Evangelin Prayogo, Willy Sandhika
GSC Biological and Pharmaceutical Sciences (2023) Vol. 25, Iss. 1, pp. 131-137
Open Access | Times Cited: 1
Möglichkeiten des personalisierten Vorgehens bei solitären Schilddrüsenknoten basierend auf molekularem Profiling
C. Chiapponi, Udo Siebolts
Deleted Journal (2023) Vol. 95, Iss. 3, pp. 179-185
Closed Access
C. Chiapponi, Udo Siebolts
Deleted Journal (2023) Vol. 95, Iss. 3, pp. 179-185
Closed Access
